Hollow Copper Sulfide Nanocubes Loaded with Pt(IV) Complexes for Cancer Multimodal Therapy.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Chemotherapy (CT) is vital for cancer treatment but faces challenges like poor drug solubility, low cell uptake, and resistance.
• Platinum drugs are widely used but exhibit limitations including toxicity and nonspecific distribution.
• Hollow copper sulfide (CuS) nanocubes offer potential for cancer photothermal therapy (PTT) due to their properties across biological windows.

Purpose of the Study:

• To synthesize hollow CuS nanocubes as carriers for Pt(IV) drugs.
• To develop a multifunctional nanoplatform for combined chemo/photothermal/photodynamic therapy (PDT).
• To enhance drug delivery and therapeutic efficacy for cancer treatment.

Main Methods:

• Synthesized hollow CuS nanocubes and loaded them with Pt(IV) complexes.
• Oxidized ethylenediamine platinum chloride to its tetravalent state for Pt(IV) drug formulation.
• Modified nanoparticle surfaces with polyethylene glycol (PEG) to enhance the enhanced permeability and retention (EPR) effect.

Main Results:

• The synthesized Pt(IV)-loaded hollow CuS nanocubes (Pt(IV)-CuS@PEG) exhibit photothermal and photodynamic properties.
• CuS nanocubes facilitate reduction of Cu2+ to Cu+ under near-infrared (NIR) laser irradiation, enabling PDT.
• Pt(IV) drugs enhance PDT by consuming glutathione (GSH) and increasing reactive oxygen species (ROS) in tumor cells.

Conclusions:

• Pt(IV)-CuS@PEG nanoparticles represent a promising strategy for synergistic chemo/photothermal/photodynamic cancer therapy.
• The nanocarrier system addresses limitations of traditional chemotherapy and enhances tumor targeting.
• This approach holds potential for improved cancer treatment outcomes with reduced systemic toxicity.